These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 14570772

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Regiochemical differences in cytochrome P450 isozymes responsible for the oxidation of methylenedioxyphenyl groups by rabbit liver.
    Kumagai Y, Lin LY, Philpot RM, Yamada H, Oguri K, Yoshimura H, Cho AK.
    Mol Pharmacol; 1992 Oct; 42(4):695-702. PubMed ID: 1435745
    [Abstract] [Full Text] [Related]

  • 23. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
    Raner GM, Vaz AD, Coon MJ.
    Mol Pharmacol; 1996 Mar; 49(3):515-22. PubMed ID: 8643091
    [Abstract] [Full Text] [Related]

  • 24. Inhibition and inactivation of human cytochrome P450 isoforms by phenethyl isothiocyanate.
    Nakajima M, Yoshida R, Shimada N, Yamazaki H, Yokoi T.
    Drug Metab Dispos; 2001 Aug; 29(8):1110-3. PubMed ID: 11454729
    [Abstract] [Full Text] [Related]

  • 25. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
    Danek PJ, Wójcikowski J, Daniel WA.
    Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
    [Abstract] [Full Text] [Related]

  • 26. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
    Lu P, Schrag ML, Slaughter DE, Raab CE, Shou M, Rodrigues AD.
    Drug Metab Dispos; 2003 Nov; 31(11):1352-60. PubMed ID: 14570767
    [Abstract] [Full Text] [Related]

  • 27. Effect of an extract of the root of Scutellaria baicalensis and its flavonoids on aflatoxin B1 oxidizing cytochrome P450 enzymes.
    Kim BR, Kim DH, Park R, Kwon KB, Ryu DG, Kim YC, Kim NY, Jeong S, Kang BK, Kim KS.
    Planta Med; 2001 Jul; 67(5):396-9. PubMed ID: 11488450
    [Abstract] [Full Text] [Related]

  • 28. In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.
    Han YL, Yu HL, Li D, Meng XL, Zhou ZY, Yu Q, Zhang XY, Wang FJ, Guo C.
    Phytother Res; 2011 Nov; 25(11):1660-5. PubMed ID: 21425377
    [Abstract] [Full Text] [Related]

  • 29. Identification of cytochrome P450 and arylamine N-acetyltransferase isoforms involved in sulfadiazine metabolism.
    Winter HR, Unadkat JD.
    Drug Metab Dispos; 2005 Jul; 33(7):969-76. PubMed ID: 15843491
    [Abstract] [Full Text] [Related]

  • 30. Analysis of goldenseal, Hydrastis canadensis L., and related alkaloids in urine using HPLC with UV detection.
    Dawes ML, Brettell T.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan 01; 880(1):114-8. PubMed ID: 22177787
    [Abstract] [Full Text] [Related]

  • 31. Mechanism-based inhibition of human liver microsomal cytochrome P450 2D6 (CYP2D6) by alkamides of Piper nigrum.
    Subehan, Usia T, Kadota S, Tezuka Y.
    Planta Med; 2006 May 01; 72(6):527-32. PubMed ID: 16808005
    [Abstract] [Full Text] [Related]

  • 32. Interactions between cytochromes P450, glutathione S-transferases and Ghanaian medicinal plants.
    Appiah-Opong R, Commandeur JN, Axson C, Vermeulen NP.
    Food Chem Toxicol; 2008 Dec 01; 46(12):3598-603. PubMed ID: 18822337
    [Abstract] [Full Text] [Related]

  • 33. An in vitro evaluation of the victim and perpetrator potential of the anticancer agent laromustine (VNP40101M), based on reaction phenotyping and inhibition and induction of cytochrome P450 enzymes.
    Nassar AE, King I, Paris BL, Haupt L, Ndikum-Moffor F, Campbell R, Usuki E, Skibbe J, Brobst D, Ogilvie BW, Parkinson A.
    Drug Metab Dispos; 2009 Sep 01; 37(9):1922-30. PubMed ID: 19520774
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Metabolite-P450 complex formation by methylenedioxyphenyl HIV protease inhibitors in rat and human liver microsomes.
    Chiba M, Nishime JA, Chen IW, Vastag KJ, Sahly YS, Kim BM, Dorsey BD, Vacca JP, Lin JH.
    Biochem Pharmacol; 1998 Jul 15; 56(2):223-30. PubMed ID: 9698076
    [Abstract] [Full Text] [Related]

  • 38. Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation.
    Akutsu T, Kobayashi K, Sakurada K, Ikegaya H, Furihata T, Chiba K.
    Drug Metab Dispos; 2007 Jan 15; 35(1):72-8. PubMed ID: 17020955
    [Abstract] [Full Text] [Related]

  • 39. Characterization of hepatic drug-metabolizing activities of Bama miniature pigs (Sus scrofa domestica): comparison with human enzyme analogs.
    Li J, Liu Y, Zhang JW, Wei H, Yang L.
    Comp Med; 2006 Aug 15; 56(4):286-90. PubMed ID: 16941956
    [Abstract] [Full Text] [Related]

  • 40. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
    Daniel WA, Kot M, Wójcikowski J.
    Pol J Pharmacol; 2003 Aug 15; 55(6):1045-53. PubMed ID: 14730100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.